Literature DB >> 16618734

High-throughput loss-of-heterozygosity study of chromosome 3p in lung cancer using single-nucleotide polymorphism markers.

Amy L S Tai1, William Mak, Phoebe K M Ng, Daniel T T Chua, Mandy Y M Ng, Li Fu, Kevin K W Chu, Yan Fang, You Qiang Song, Muhan Chen, Minyue Zhang, Pak C Sham, Xin-Yuan Guan.   

Abstract

Loss of DNA copy number at the short arm of chromosome 3 is one of the most common genetic changes in human lung cancer, suggesting the existence of one or more tumor suppressor genes (TSG) at 3p. To identify most frequently deleted regions and candidate TSGs within these regions, a recently developed single-nucleotide polymorphism (SNP)-mass spectrometry-genotyping (SMSG) technology was applied to investigate the loss of heterozygosity (LOH) in 30 primary non-small-cell lung cancers. A total of 386 SNP markers that spanned a region of 70 Mb at 3p, from 3pter to 3p14.1, were selected for LOH analysis. The average intermarker distance in the present study is approximately 180 kb. Several frequently deleted regions, including 3p26.3, 3p25.3, 3p24.1, 3p23, and 3p21.1, were found. Several candidate TSGs within these frequently detected LOH regions have been found, including APG7L at 3p25.3, CLASP2 at 3p23, and CACNA2D3 at 3p21.1. This study also showed that SMSG technology is a very useful approach to rapidly define the minimal deleted region and to identify target TSGs in a given cancer.

Entities:  

Mesh:

Year:  2006        PMID: 16618734     DOI: 10.1158/0008-5472.CAN-05-2775

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

1.  Frequent loss of heterozygosity on chromosome 12q in non-small-cell lung carcinomas.

Authors:  Xiao-Jie Ding; Min-Xia Liu; Lei Ao; Yi-Rong Liang; Yi Cao
Journal:  Virchows Arch       Date:  2011-01-29       Impact factor: 4.064

2.  Homozygously deleted gene DACH1 regulates tumor-initiating activity of glioma cells.

Authors:  Akira Watanabe; Hideki Ogiwara; Shogo Ehata; Akitake Mukasa; Shumpei Ishikawa; Daichi Maeda; Keisuke Ueki; Yasushi Ino; Tomoki Todo; Yasuhiro Yamada; Masashi Fukayama; Nobuhito Saito; Kohei Miyazono; Hiroyuki Aburatani
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-12       Impact factor: 11.205

3.  Identification of functional cooperative mutations of SETD2 in human acute leukemia.

Authors:  Xiaofan Zhu; Fuhong He; Huimin Zeng; Shaoping Ling; Aili Chen; Yaqin Wang; Xiaomei Yan; Wei Wei; Yakun Pang; Hui Cheng; Chunlan Hua; Yue Zhang; Xuejing Yang; Xin Lu; Lihua Cao; Lingtong Hao; Lili Dong; Wei Zou; Jun Wu; Xia Li; Si Zheng; Jin Yan; Jing Zhou; Lixia Zhang; Shuangli Mi; Xiaojuan Wang; Li Zhang; Yao Zou; Yumei Chen; Zhe Geng; Jianmin Wang; Jianfeng Zhou; Xin Liu; Jianxiang Wang; Weiping Yuan; Gang Huang; Tao Cheng; Qian-Fei Wang
Journal:  Nat Genet       Date:  2014-02-09       Impact factor: 38.330

4.  Genome-wide single nucleotide polymorphism array analysis reveals recurrent genomic alterations associated with histopathologic features in intrahepatic cholangiocarcinoma.

Authors:  Wan-Ting Huang; Shao-Wen Weng; Yu-Ching Wei; Huey-Ling You; Jui-Tzu Wang; Hock-Liew Eng
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

5.  Genome-wide association study to identify novel loci associated with therapy-related myeloid leukemia susceptibility.

Authors:  Jeffrey A Knight; Andrew D Skol; Abhijit Shinde; Darcie Hastings; Richard A Walgren; Jin Shao; Thelma R Tennant; Mekhala Banerjee; James M Allan; Michelle M Le Beau; Richard A Larson; Timothy A Graubert; Nancy J Cox; Kenan Onel
Journal:  Blood       Date:  2009-03-18       Impact factor: 22.113

6.  Mutation analysis of Rad18 in human cancer cell lines and non small cell lung cancer tissues.

Authors:  Tadahiko Nakamura; Shinji Ishikawa; Yoshikatsu Koga; Youhei Nagai; Yu Imamura; Kouei Ikeda; Takeshi Mori; Hiroaki Nomori; Hideo Baba
Journal:  J Exp Clin Cancer Res       Date:  2009-07-25

Review 7.  Cancer the'RBP'eutics-RNA-binding proteins as therapeutic targets for cancer.

Authors:  Shakur Mohibi; Xinbin Chen; Jin Zhang
Journal:  Pharmacol Ther       Date:  2019-07-11       Impact factor: 12.310

Review 8.  Tumor suppressor genes on frequently deleted chromosome 3p in nasopharyngeal carcinoma.

Authors:  Juan Chen; Li Fu; Li-Yi Zhang; Dora L Kwong; Li Yan; Xin-Yuan Guan
Journal:  Chin J Cancer       Date:  2012-02-24

9.  Identification of genes with allelic imbalance on 6p associated with nasopharyngeal carcinoma in southern Chinese.

Authors:  Yan Li; Li Fu; Alissa Michelle Go Wong; Yan-Hui Fan; Miao-Xin Li; Jin-Xin Bei; Wei-Hua Jia; Yi-Xin Zeng; Danny Chan; Kenneth M C Cheung; Pak Sham; Daniel Chua; Xin-Yuan Guan; You-Qiang Song
Journal:  PLoS One       Date:  2011-01-20       Impact factor: 3.240

10.  Investigation of tumor suppressing function of CACNA2D3 in esophageal squamous cell carcinoma.

Authors:  Yan Li; Cai-Lei Zhu; Chang-Jun Nie; Jiang-Chao Li; Ting-ting Zeng; Jie Zhou; Jinna Chen; Kai Chen; Li Fu; Haibo Liu; Yanru Qin; Xin-Yuan Guan
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.